Hydrogen and therapeutic gases for neonatal hypoxic-ischemic encephalopathy: potential neuroprotective adjuncts in translational research.
Yinmon Htun, Shinji Nakamura, Takashi Kusaka · Pediatric research · 2021
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This narrative review examined the available molecular-hydrogen literature. Hydrogen gas, a promising neuroprotective agent, has been a focus of study due to its potent antioxidative properties. The reviewed evidence supports molecular hydrogen's therapeutic potential. Additional well-designed studies are needed to clarify clinical safety and effectiveness.
Main Findings Across the Literature
Hydrogen gas, a promising neuroprotective agent, has been a focus of study due to its potent antioxidative properties.
Areas of Agreement or Uncertainty
Here, the researchers review therapeutic gases, particularly hydrogen, and their potentials and limitations in the treatment of HIE in newborns.
Limitations Reported by the Authors
Here, the researchers review therapeutic gases, particularly hydrogen, and their potentials and limitations in the treatment of HIE in newborns.